MONTE ROSA THERAPEUTICS INC
NASDAQ: GLUE (Monte Rosa Therapeutics, Inc.)
最近更新时间: 3小时之前17.75
-0.75 (-4.05%)
| 前收盘价格 | 18.50 |
| 收盘价格 | 18.08 |
| 成交量 | 1,831,015 |
| 平均成交量 (3个月) | 1,583,939 |
| 市值 | 1,353,308,928 |
| 市盈率 (P/E TTM) | 55.47 |
| 价格/销量 (P/S) | 3.54 |
| 股市价格/股市净资产 (P/B) | 1.76 |
| 52周波幅 | |
| 利润日期 | 19 Mar 2026 |
| 营业毛利率 | 3.86% |
| 营业利益率 (TTM) | 51.85% |
| 稀释每股收益 (EPS TTM) | 0.120 |
| 季度收入增长率 (YOY) | 7,882.00% |
| 总债务/股东权益 (D/E MRQ) | 15.21% |
| 流动比率 (MRQ) | 5.61 |
| 营业现金流 (OCF TTM) | 34.67 M |
| 杠杆自由现金流 (LFCF TTM) | 40.54 M |
| 资产报酬率 (ROA TTM) | -0.40% |
| 股东权益报酬率 (ROE TTM) | 2.88% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Monte Rosa Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 3.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | -3.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.00 |
|
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 0.73% |
| 机构持股比例 | 101.33% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Nea Management Company, Llc | 31 Dec 2025 | 7,692,298 |
| Versant Venture Management, Llc | 31 Dec 2025 | 4,382,687 |
| Suvretta Capital Management, Llc | 31 Dec 2025 | 3,360,000 |
| Aisling Capital Management Lp | 31 Dec 2025 | 1,472,331 |
| Mpm Bioimpact Llc | 31 Dec 2025 | 1,173,376 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 37.00 (Piper Sandler, 108.45%) | 购买 |
| 中 | 34.00 (91.55%) | |
| 低 | 30.00 (Wells Fargo, 69.01%) | 购买 |
| 平均值 | 33.67 (89.69%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 24.89 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Piper Sandler | 14 Jan 2026 | 37.00 (108.45%) | 购买 | 24.06 |
| Guggenheim | 08 Jan 2026 | 34.00 (91.55%) | 购买 | 25.31 |
| Wells Fargo | 08 Jan 2026 | 30.00 (69.01%) | 购买 | 25.31 |
| 16 Dec 2025 | 22.00 (23.94%) | 购买 | 18.66 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| JANKU FILIP | - | 19.51 | -9,189 | -179,277 |
| 累积净数量 | -9,189 | |||
| 累积净值 ($) | -179,277 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 19.51 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| JANKU FILIP | 职员 | 23 Feb 2026 | 卖 (-) | 9,189 | 19.51 | 179,277 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合